Franziska Preuss

Title: Franziska Preuss: Innovator in Antisense Drug Development

Introduction

Franziska Preuss is a notable inventor based in Lübeck, Germany. She has made significant contributions to the field of veterinary medicine, particularly in the development of antisense drugs. With a total of 2 patents, her work focuses on innovative treatments for inflammatory diseases in canines.

Latest Patents

Franziska Preuss's latest patents include groundbreaking research on antisense drugs targeting canine ICAM-1. These drugs are designed for use in the treatment of inflammation of the buccal cavity in canine subjects. The invention relates to an isolated antisense oligonucleotide that aims to prevent or treat inflammatory diseases or conditions affecting the buccal cavity. Additionally, the patents encompass compositions or articles of manufacture that include this antisense oligonucleotide.

Career Highlights

Franziska Preuss is affiliated with the University of Lübeck, where she conducts her research and development work. Her innovative approach to veterinary medicine has garnered attention and respect within the scientific community.

Collaborations

Franziska collaborates with esteemed colleagues, including Rosel Kretschmer-Kazemi Far and Georg Sczakiel. These partnerships enhance her research efforts and contribute to the advancement of veterinary therapeutics.

Conclusion

Franziska Preuss stands out as an influential inventor in the field of antisense drug development for canines. Her contributions are paving the way for new treatments that can significantly improve the health and well-being of dogs suffering from inflammatory conditions.